298 related articles for article (PubMed ID: 8420131)
1. Parkinson's disease and the adaptive capacity of the nigrostriatal dopamine system: possible neurochemical mechanisms.
Hornykiewicz O
Adv Neurol; 1993; 60():140-7. PubMed ID: 8420131
[No Abstract] [Full Text] [Related]
2. The nigrostriatal system in Parkinson's disease.
Graybiel AM; Hirsch EC; Agid Y
Adv Neurol; 1990; 53():17-29. PubMed ID: 1978514
[TBL] [Abstract][Full Text] [Related]
3. Biochemical aspects of Parkinson's disease.
Nagatsu T
Adv Neurol; 1993; 60():165-74. PubMed ID: 8093575
[No Abstract] [Full Text] [Related]
4. Pathogenesis and animal studies of Parkinson's disease.
Oertel WH; Kupsch A
Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):323-32. PubMed ID: 8507901
[TBL] [Abstract][Full Text] [Related]
5. Plasticity of nerve afferents to nigrostriatal neurons in Parkinson's disease.
Anglade P; Tsuji S; Javoy-Agid F; Agid Y; Hirsch EC
Ann Neurol; 1995 Feb; 37(2):265-72. PubMed ID: 7847868
[TBL] [Abstract][Full Text] [Related]
6. Basic research on dopamine in Parkinson's disease and the discovery of the nigrostriatal dopamine pathway: the view of an eyewitness.
Hornykiewicz O
Neurodegener Dis; 2008; 5(3-4):114-7. PubMed ID: 18322366
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of action of short- and long-term L-DOPA treatment in parkinsonism: role of the surviving nigrostriatal dopaminergic neurons.
Melamed E; Hefti F
Adv Neurol; 1984; 40():149-57. PubMed ID: 6695591
[No Abstract] [Full Text] [Related]
8. Dopaminergic activation of Fos and the rat model of Parkinson's disease.
Cole DG
Adv Neurol; 1993; 60():334-7. PubMed ID: 8380526
[No Abstract] [Full Text] [Related]
9. Role of neostriatal and mesostriatal or mesolimbic dopaminergic fibres in Parkinson's disease with and without dementia: prospects, concepts and facts.
Cools AR
Yakubutsu Seishin Kodo; 1990 Mar; 10(1):15-34. PubMed ID: 2220127
[No Abstract] [Full Text] [Related]
10. [The neuropsychology of nigrostriatal dopaminergic transmission in Parkinson's disease].
Wallesch C
Fortschr Neurol Psychiatr; 2011 Dec; 79(12):692-5. PubMed ID: 22009273
[TBL] [Abstract][Full Text] [Related]
11. Nigrostriatal system plasticity in Parkinson's disease: effect of dopaminergic denervation and treatment.
Hirsch EC
Ann Neurol; 2000 Apr; 47(4 Suppl 1):S115-20; discussion S120-1. PubMed ID: 10762138
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial energy crisis in Parkinson's disease.
Mizuno Y; Ikebe S; Hattori N; Kondo T; Tanaka M; Ozawa T
Adv Neurol; 1993; 60():282-7. PubMed ID: 8420144
[No Abstract] [Full Text] [Related]
13. Role of the nigrostriatal dopaminergic neurons in mediating the effect of exogenous L-dopa in Parkinson's disease.
Melamed E
Mt Sinai J Med; 1988 Jan; 55(1):35-42. PubMed ID: 3279303
[No Abstract] [Full Text] [Related]
14. Gender differences in neurotoxicity of the nigrostriatal dopaminergic system: implications for Parkinson's disease.
Dluzen DE; McDermott JL
J Gend Specif Med; 2000; 3(6):36-42. PubMed ID: 11253381
[TBL] [Abstract][Full Text] [Related]
15. Clinical features, diagnosis, and imaging of parkinsonian syndromes.
Poewe W
Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):333-8. PubMed ID: 8507902
[TBL] [Abstract][Full Text] [Related]
16. [Search for the cause of Parkinson's disease].
Langston JW
Arch Neurobiol (Madr); 1991; 54(6):264-71. PubMed ID: 1811457
[No Abstract] [Full Text] [Related]
17. Early and late molecular events occurring following neuronal degeneration in the dopamine system.
Joh TH; Weiser M
Adv Neurol; 1993; 60():316-20. PubMed ID: 8093580
[TBL] [Abstract][Full Text] [Related]
18. [Huntington chorea. Review of the most recent aspects of research].
Albano C; Farinini D; Tassinari T; Caponnetto C; Bacigalupo F
Riv Neurol; 1985; 55(4):247-55. PubMed ID: 2997905
[TBL] [Abstract][Full Text] [Related]
19. "Ottorino Rossi" Award 2000. New targets for therapy in Parkinson's disease: pathogenesis and pathophysiology.
Greenamyre JT
Funct Neurol; 2000; 15(2):67-80. PubMed ID: 10916718
[No Abstract] [Full Text] [Related]
20. The dopaminergic nigrostriatal system and Parkinson's disease: molecular events in development, disease, and cell death, and new therapeutic strategies.
Hodaie M; Neimat JS; Lozano AM
Neurosurgery; 2007 Jan; 60(1):17-28; discussion 28-30. PubMed ID: 17228250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
